StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) income statement

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

COSCIENS Biopharma Inc. income statement

Ratios

Latest available, balances at Mar 31, 2026

Profitability, TTM

Gross margin
38.0%
Operating margin
-98.8%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
5.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
297.0%

Valuation

P/E ratio
–
Price to sales
3.06
Price to book
1.57
Dividend yield
–

See a number that looks wrong?